Avenzo Therapeutics raised $150M in a Series A-1 financing led by New Enterprise Associates (NEA), Deep Track Capital, Sofinnova Investments, and Sands Capital to advance emerging oncology pipeline.
Amount Raised
$150 Million
Round Type
Series A
San DiegoBiotechnologyTherapeuticsPharmaceuticalInvestors
Description
Avenzo Therapeutics, Inc. announced an oversubscribed $150 million Series A-1 financing, bringing the total capital raised since the company’s founding to $347 million. The financing round includes nine new investors and was led by New Enterprise Associates (NEA), Deep Track Capital, Sofinnova Investments, and Sands Capital. The proceeds from the financing will be used to advance Avenzo’s emerging oncology pipeline, particularly the potentially best-in-class cyclin-dependent kinase 2 (CDK2) selective inhibitor AVZO-021.
Quick answer
Avenzo Therapeutics raised $150 Million in a Series A round, dated March 26, 2024. Investors: Surveyor Capital, New Enterprise Associates, Lilly Asia Ventures, SR One, Foresite Capital, Orbi Med, Quan Capital and Delos Capital. Avenzo Therapeutics is based in San Diego, California, United States.
- How much did Avenzo Therapeutics raise?
- Avenzo Therapeutics raised $150 Million in a Series A round on March 26, 2024.
- Who invested in Avenzo Therapeutics?
- Surveyor Capital, New Enterprise Associates, Lilly Asia Ventures, SR One, Foresite Capital, Orbi Med, Quan Capital and Delos Capital are named as investors in this round.
- What does Avenzo Therapeutics do?
- Avenzo Therapeutics is a clinical-stage biotechnology company focused on developing the next generation of oncology therapies for patients.
- Where is Avenzo Therapeutics based and how big is it?
- Avenzo Therapeutics is based in San Diego, California, United States. Fundz records about 2 employees.
- Who are the decision-makers at Avenzo Therapeutics?
- Fundz holds 2 contacts at Avenzo Therapeutics, including the Senior Director Human Resources. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Pharmaceutical around the same time
Companies in the same sectors as Avenzo Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Cerenome, Inc. raised $18M (Post-IPO Equity) on May 6, 2024.
- Bio Green Med Solution, Inc. raised $8M on May 2, 2024.
- Ajax Therapeutics, Inc. raised $95M on April 26, 2024.
- Brise Pharmaceuticals LTD raised $20M (Funding Round) on April 23, 2024.
- TORL BioTherapeutics raised $158M (Series B) on April 10, 2024.
- Seaport Therapeutics raised $100M (Series A) on April 9, 2024.
Who to call at Avenzo Therapeutics, and when
A new round usually means Avenzo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Avenzo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Avenzo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Avenzo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Avenzo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAvenzo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.